Daniel Higazi

Daniel Higazi has extensive experience in the biopharmaceutical industry, currently serving as Vice President of Biologics Pharmaceutical Development (CMC) at Ipsen since May 2016, after previously holding the position of Director of Global Analytical Development CMC. Prior to Ipsen, Daniel worked at MedImmune (a member of the AstraZeneca Group) from 2008 to 2016 as a Senior Scientist/R&D Manager in Biopharmaceutical Development. Earlier experience includes roles as a Research Scientist at Eisai EMEA and Rodaris Pharmaceuticals, as well as a Research Associate at Imperial College London. Daniel holds a Bachelor of Science (BSc) in Biochemistry from Imperial College London and a PhD in Biochemistry from the University of Cambridge.